China Medical System Holdings Limited Stock

Stocks

867

KYG211081248

Pharmaceuticals

OTC Markets Traded
Market Closed - Hong Kong S.E. 16:08:21 12/06/2026 HKT 5-day change 1st Jan Change
11.00 HKD +1.66% Intraday chart for China Medical System Holdings Limited +3.29% -14.73%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: China Medical System Holdings Limited

Market Cap 22.99B 26.63B 3.4B 2.93B 2.7B 2.53B 4.74B 323B 4.82B 31.93B 12.45B 157B 12.75B 12.48B 544B P/E Ratio 2026 *
11.3x
P/E Ratio 2027 * 9.67x
Enterprise Value 20.57B 23.82B 3.04B 2.63B 2.42B 2.26B 4.24B 289B 4.31B 28.57B 11.14B 141B 11.41B 11.17B 487B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.73x
Free-Float
51.73%
Yield 2026 *
3.88%
Yield 2027 * 4.37%
06-08 China Medical System Holdings Limited Presents Preclinical Results of Self-Developed Innovative INHBE-Targeting siRNA Drug CMS-D008 At ADA Scientific Sessions CI
05-29 China Medical System Holdings Limited commences an Equity Buyback Plan for 243,952,851 shares, representing 10% of its issued share capital, under the authorization approved on April 23, 2026. CI
05-26 China Medical System says NPMA approved CMS-D001 granted drug clinical trial RE
05-26 China Medical System Gets China Trial Approval for Crohn's, Colitis Drug MT
04-24 China Medical System Holdings Limited Approves Final Dividend for the Year Ended December 31, 2025 CI
04-23 China Medical System Gets China Acceptance for Seasonal Allergic Rhinitis Drug Indication of MG-K10 MT
04-23 China Medical System Holdings Limited Announces Acceptance of New Drug Application for Seasonal Allergic Rhinitis Indication of Mg-K10 in China CI
03-17 China Medical System's Profit Slides in 2025 MT
03-17 China Medical System posts FY turnover up 9.9% to RMB8,212.1 million RE
03-16 China Medical System Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-16 China Medical System posts profit for year RMB1,443.3 million RE
03-16 China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2025, Payable on About 7 May 2026 CI
03-16 China Medical System Holdings Limited Appoints Luo Laura Ying as Member of the Environment, Social and Governance Committee, Effective from 16 March, 2026 CI
1 day+1.66%
1 week+3.29%
Current month+3.97%
1 month-7.17%
3 months-13.45%
6 months-18.94%
Current year-14.73%
1 week 10
Extreme 10
11.12
1 month 10
Extreme 10
11.7
Current year 10
Extreme 10
15.52
1 year 10
Extreme 10
15.63
3 years 6.23
Extreme 6.23
15.86
5 years 6.23
Extreme 6.23
21.85
10 years 6.14
Extreme 6.14
22.8
Manager TitleAgeSince
Chief Executive Officer 61 31/03/2020
Director of Finance/CFO 55 -
Chief Investment Officer 50 01/01/2022
Director TitleAgeSince
Chairman 61 18/12/2006
Director/Board Member 55 18/12/2006
Director/Board Member 60 13/12/2017
Date Insider Type Main position Quantity % Market Cap.
23/09/24Other

Chief Executive Officer

500,000 0.0205%
20/09/24Other

Chief Executive Officer

500,000 0.0205%
17/09/24Other

Chief Executive Officer

500,000 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
+1.66%+3.29%-2.83%-11.29% 3.4B
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%+0.89%+22.36%+17.73% 330B
+0.44%+3.48%+25.65%+35.66% 281B
-0.85%-2.86%+22.54%+14.67% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
-0.22%-2.76%+14.19%+60.09% 156B
Average +0.44%+1.06%+16.87%+39.82% 343.23B
Weighted average by Cap. -0.16%+1.01%+27.84%+70.56%

Financials

2026 *2027 *
Net sales 9.86B 11.42B 1.46B 1.26B 1.16B 1.09B 2.03B 138B 2.07B 13.69B 5.34B 67.41B 5.47B 5.35B 233B 11.63B 13.47B 1.72B 1.48B 1.37B 1.28B 2.4B 163B 2.44B 16.16B 6.3B 79.53B 6.45B 6.31B 275B
Net income 2.02B 2.34B 299M 258M 238M 222M 417M 28.37B 423M 2.81B 1.09B 13.81B 1.12B 1.1B 47.82B 2.38B 2.76B 352M 304M 280M 263M 492M 33.49B 500M 3.31B 1.29B 16.3B 1.32B 1.29B 56.45B
Net Debt -2.42B -2.8B -358M -309M -285M -267M -500M -34.01B -507M -3.36B -1.31B -16.56B -1.34B -1.31B -57.33B -2.89B -3.35B -427M -369M -340M -318M -597M -40.62B -606M -4.02B -1.57B -19.77B -1.6B -1.57B -68.46B
Logo China Medical System Holdings Limited
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Employees
6,415
Date Price Change Volume
12/06/26 11.00 $ +1.66% 7,282,045
11/06/26 10.82 $ -0.46% 3,252,070
10/06/26 10.87 $ +5.53% 4,203,000
09/06/26 10.30 $ -0.48% 6,352,712
08/06/26 10.35 $ -2.82% 7,670,744
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.500CNY
Average target price
15.52CNY
Spread / Average Target
+63.38%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!